The company Swiss Rockets AG will build a new innovation center for nuclear medicine within the BIO4 campus, stated the Minister of Science, Technological Development and Innovation Jelena Begović.
Begović and CEO of Swiss Rockets AG Vladimir Cmiljanović signed a Memorandum of Understanding in the Government of Serbia, “opening up new opportunities for the development of oncology and nuclear medicine”.
After signing the Memorandum, Begović explained that our people who live and work in Switzerland are the founders of an innovative company, i.e. a network of Swiss Rockets AG companies, with a large number of innovations in their portfolio, and that they decided to take this step and transfer their knowledge and technologies to Serbia.
The minister added that the company will also help the development of the startup ecosystem in the field of biotechnology in Serbia and that it has already started cooperation with our scientific research institutes, such as INEP and the Institute of Chemistry, Technology and Metallurgy (IHTM). Those institutes are the future tenants of the BIO4 campus, and this is the first concrete project with a Swiss company, she said.
Cmiljanović pointed out that the company decided to enter into cooperation with our country for making the so-called theranostic innovation center.
“These are the most modern hospitals, where we will produce the latest molecules for personalized cancer medicine.” We will work with the latest technologies for scanning patients with metastases and then, based on those technologies, we will be able to use those molecules in order to successfully treat patients with metastases,” explained Cmiljanović.
He added that this company from Switzerland transfers very important technologies to Serbia, as well as that these technologies will be further developed in our country.
The BIO4 campus should bring together nine scientific institutes, wrote New Economy.
These are the Institute for Molecular Genetics and Genetic Engineering, the Center for Sustainable Management of Bioresources and Natural Products of the Institute for Biological Research “Siniša Stanković”, the Institute for Medical Research, the Institute for Multidisciplinary Research, the Research and Development Institute for Artificial Intelligence of Serbia, the Institute “Biosens”, the Institute for Cardiovascular Diseases “Dedinje”, the Institute for the Application of Nuclear Energy (INEP) and the Institute for Chemistry, Technology and Metallurgy.
It should also include five faculties of the University of Belgrade – Faculty of Pharmacy, Faculty of Biology, Faculty of Agriculture, Faculty of Medicine and Faculty of Technology and Metallurgy.
In addition, the campus will also house the development centers of private companies. So far, Serbia has signed memoranda of cooperation in the BIO4 campus with the company “Roche”, “Merch Sharp and Dohme”, “BGI” and “Takeda”. The campus will focus on four themes, biomedicine, biotechnology, bioinformatics and biodiversity.